ABSTRACT INTRODUCTION: Invasive fungal infections (IFIs) are an important complication in immunocompromised individuals, particularly neutropenic patients with hematological malignancies. In this stud
Introduction: The real-world safety profiles of the demethylating agents Azacitidine and Decitabine remain inadequately characterized despite their widespread clinical use. Both drugs are extensively
Tabulation of all subjects for disease classification (Salmon-Durie), hematologic response, and additional chemotherapeutic agents used according to treatment group.
